JDD HighlightsSkin of Color

View the Latest Skin of Color, Anti-Aging, Aesthetic, and Medical Dermatology Articles Now

By June 30, 2020March 5th, 2026No Comments

Dermatology News

JDD Highlights

The July issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin of Color, with special features on Anti-Aging, Aesthetic, and Medical Dermatology.
Read the JDD Now

Skin of Color, Anti-Aging, Aesthetic, and Medical Dermatology

The July issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin of Color, with special features on Anti-Aging, Aesthetic, and Medical Dermatology.

Article Highlights

Editor's Picks

You May Also Like

Journal of Drugs in Dermatology JDD featuring Diagnostic Accuracy and Pitfalls of Publicly Available Artificial Intelligence Models for Nail Disorders

Diagnostic Accuracy and Pitfalls of Publicly Available Artificial Intelligence Models for Nail Disorders

| Featured Articles, Latest News, Nails, Social and Technology | No Comments
AI in Dermatology: Vision Language Models Show Limited Accuracy for Nail Disorders in JDD Study In case you missed it, check out this article from the JDD. A recent study…
Journal of Drugs in Dermatology JDD featuring Objective Measures Needed: Dermatology Program Directors' Perspectives on the USMLE Step 1 Pass/Fail Transition

Objective Measures Needed: Dermatology Program Directors’ Perspectives on the USMLE Step 1 Pass/Fail Transition

| Education, Featured Articles, Latest News | No Comments
JDD Survey: How Dermatology Program Directors Are Responding to Step 1 Pass/Fail Have you read this article from the JDD? A new survey of dermatology residency program directors examine how…
Journal of Drugs in Dermatology JDD Article about Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions

Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions

| Featured Articles, Latest News, Medical Derm | No Comments
Phase 3 data report rapid, clinically meaningful symptom reduction with a tolerable safety profile; early hidradenitis suppurativa signals broaden interest Hot off the pages of JDD, this timely review synthesizes…

Leave a Reply